Published : Jul-2017
No. of Pages : 179
Table of Contents 2
List of Tables 3
List of Figures 4
Report Guidance 5
GlobalData Clinical Trials Report Coverage 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 11
Top Five Countries Contributing to Clinical Trials in Europe 12
Top Countries Contributing to Clinical Trials in North America 13
Top Countries Contributing to Clinical Trials in Middle East and Africa 14
Top Countries Contributing to Clinical Trials in Central and South America 15
Clinical Trials by G7 Countries: Proportion of Delirium to Central Nervous System Clinical Trials 16
Clinical Trials by Phase in G7 Countries 18
Clinical Trials in G7 Countries by Trial Status 19
Clinical Trials by E7 Countries: Proportion of Delirium to Central Nervous System Clinical Trials 21
Clinical Trials by Phase in E7 Countries 23
Clinical Trials in E7 Countries by Trial Status 24
Clinical Trials by Phase 26
In Progress Trials by Phase 27
Clinical Trials by Trial Status 28
Clinical Trials by End Point Status 30
Subjects Recruited Over a Period of Time 31
Clinical Trials by Sponsor Type 32
Prominent Sponsors 33
Top Companies Participating in Delirium Therapeutics Clinical Trials 35
Prominent Drugs 37
Clinical Trial Profile Snapshots 38
Appendix 177
Abbreviations 177
Definitions 177
Research Methodology 178
Secondary Research 178
About GlobalData 179
Contact Us 179
Source 179
List of Tables
Delirium Therapeutics, Global, Clinical Trials by Region, 2017* 7
Delirium Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2017* 9
Delirium Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2017* 10
Delirium Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2017* 11
Delirium Therapeutics Clinical Trials, Europe, Top Five Countries, 2017* 12
Delirium Therapeutics Clinical Trials, North America, Top Countries, 2017* 13
Delirium Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2017* 14
Delirium Therapeutics Clinical Trials, Central and South America, Top Countries, 2017* 15
Proportion of Delirium to Central Nervous System Clinical Trials, G7 Countries (%), 2017* 17
Delirium Therapeutics, G7 Countries, Clinical Trials by Phase, 2017* 18
Delirium Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2017* 20
Proportion of Delirium to Central Nervous System Clinical Trials, E7 Countries (%), 2017* 22
Delirium Therapeutics, E7 Countries, Clinical Trials by Phase, 2017* 23
Delirium Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2017* 25
Delirium Therapeutics, Global, Clinical Trials by Phase, 2017* 26
Delirium Therapeutics, Global, Clinical Trials In Progress by Phase 2017* 27
Delirium Therapeutics, Global, Clinical Trials by Trial Status, 2017* 29
Delirium Therapeutics Clinical Trials, Global, by End Point Status, 2017* 30
Delirium Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2012-2016 31
Delirium Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2017* 32
Delirium Therapeutics Clinical Trials, Global, Key Sponsors, 2017* 34
Delirium Therapeutics Clinical Trials, Global, Top Companies by Phase, 2017* 36
Delirium Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2017* 37
List of Figures
Delirium Therapeutics, Global, Clinical Trials by Region (%), 2017* 7
Delirium Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2017* 8
Delirium Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2017* 10
Delirium Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2017* 11
Delirium Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2017* 12
Delirium Therapeutics Clinical Trials, North America, Top Countries (%), 2017* 13
Delirium Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2017* 14
Delirium Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2017* 15
Proportion of Delirium to Central Nervous System Clinical Trials, G7 Countries (%), 2017* 16
Delirium Therapeutics, G7 Countries, Clinical Trials by Phase, 2017* 18
Delirium Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2017* 19
Proportion of Delirium to Central Nervous System Clinical Trials, E7 Countries (%), 2017* 21
Delirium Therapeutics, E7 Countries, Clinical Trials by Phase, 2017* 23
Delirium Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2017* 24
Delirium Therapeutics, Global, Clinical Trials by Phase (%), 2017* 26
Delirium Therapeutics, Global, Clinical Trials In Progress by Phase, 2017* 27
Delirium Therapeutics, Global, Clinical Trials by Trial Status, 2017* 28
Delirium Therapeutics Clinical Trials, Global, by End Point Status, 2017* 30
Delirium Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2012-2016 31
Delirium Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2017* 32
Delirium Therapeutics Clinical Trials, Global, Key Sponsors, 2017* 33
Delirium Therapeutics Clinical Trials, Global, Top Companies by Phase, 2017* 35
Delirium Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2017* 37
GlobalData Methodology 178
